LL-37
LL-37
Also known as: Cathelicidin, hCAP-18 Fragment, CAMP
Overview
Key Facts
Primary Goal: The only human cathelicidin, a 37-amino acid antimicrobial peptide cleaved from the C-terminus of hCAP-18
The only human cathelicidin, a 37-amino acid antimicrobial peptide cleaved from the C-terminus of hCAP-18. Functions as a critical component of innate immunity with direct pathogen-killing activity and potent immunomodulatory effects. Half-Life ~4 hours Typical Dose 50–100 mcg Frequency 1x daily or every other day Cycle Length 4-8 weeks
Dosing Information
Half-Life
~4 hours
Typical Dose
50–100 mcg
Frequency
1x daily or every other day
Cycle Length
4-8 weeks
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Extensively studied innate immune peptide with over 2,000 published papers. Phase 1 clinical trials conducted for chronic wound healing (OP-145, a derivative). Strong preclinical data for biofilm-associated infections, diabetic wound healing, and adjunct antibiotic therapy. Vitamin D-dependent expression explains some immune benefits of vitamin D supplementation.
Frequently Asked Questions
Common questions about LL-37
UK-Specific Information
Exclusive data points and guidance for UK residents using LL-37
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.